These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30011904)

  • 1. Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations.
    Gupta D; Bhatia D; Dave V; Sutariya V; Varghese Gupta S
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30011904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".
    Korn C; Balbach S
    Eur J Pharm Sci; 2014 Jun; 57():257-63. PubMed ID: 24036162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-clinical toxicological considerations for pharmaceutical salt selection.
    Thackaberry EA
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1419-33. PubMed ID: 22950715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of salt screening methodologies.
    Fernández Casares A; Nap WM; Ten Figás G; Huizenga P; Groot R; Hoffmann M
    J Pharm Pharmacol; 2015 Jun; 67(6):812-22. PubMed ID: 25683791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case study where pharmaceutical salts were used to address the issue of low in vivo exposure.
    Sigfridsson K; Ulvinge ML; Svensson L; Granath AK
    Drug Dev Ind Pharm; 2019 Feb; 45(2):202-211. PubMed ID: 30256689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
    He Y; Orton E; Yang D
    J Pharm Sci; 2018 Jan; 107(1):419-425. PubMed ID: 29107790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salt formation to improve drug solubility.
    Serajuddin AT
    Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges.
    Cerreia Vioglio P; Chierotti MR; Gobetto R
    Adv Drug Deliv Rev; 2017 Aug; 117():86-110. PubMed ID: 28687273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystalline vs. ionic liquid salt forms of active pharmaceutical ingredients: a position paper.
    Stoimenovski J; MacFarlane DR; Bica K; Rogers RD
    Pharm Res; 2010 Apr; 27(4):521-6. PubMed ID: 20143257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformulation investigation and challenges; salt formation, salt disproportionation and hepatic recirculation.
    Sigfridsson K; Nilsson L; Ahlqvist M; Andersson T; Granath AK
    Eur J Pharm Sci; 2017 Jun; 104():262-272. PubMed ID: 28366653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism and crystallization of active pharmaceutical ingredients (APIs).
    Lu J; Rohani S
    Curr Med Chem; 2009; 16(7):884-905. PubMed ID: 19275600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in active pharmaceutical ingredient salt selection based on analysis of the Orange Book database.
    Paulekuhn GS; Dressman JB; Saal C
    J Med Chem; 2007 Dec; 50(26):6665-72. PubMed ID: 18052022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salt disproportionation: A material science perspective.
    Thakral NK; Kelly RC
    Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
    Kawakami K
    Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement and Accurate Interpretation of the Solubility of Pharmaceutical Salts.
    He Y; Ho C; Yang D; Chen J; Orton E
    J Pharm Sci; 2017 May; 106(5):1190-1196. PubMed ID: 28153596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques.
    Pindelska E; Sokal A; Kolodziejski W
    Adv Drug Deliv Rev; 2017 Aug; 117():111-146. PubMed ID: 28931472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
    David SE; Timmins P; Conway BR
    Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical salts: a summary on doses of salt formers from the Orange Book.
    Saal C; Becker A
    Eur J Pharm Sci; 2013 Jul; 49(4):614-23. PubMed ID: 23747999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design.
    Berry DJ; Steed JW
    Adv Drug Deliv Rev; 2017 Aug; 117():3-24. PubMed ID: 28344021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.